Joint Infection clinical trials

Explore recruiting joint infection clinical trials.

Recruiting joint infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Joint Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in addition to Minimum Inhibitory Concentration (MIC) to guide the treatment of periprosthetic joint infections; a prospective randomized clinical trial

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Rifampicin Combination Therapy versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-reported outcomes on quality of life • Local bone and soft tissue concentrations • Effect on the gut microbiome A randomised controlled study of dalbavancin versus standard antibiotic treatment of Gram-positive periprosthetic joint infections.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Impact of rifampicin in treatment outcome of Cutibacterium spp. prosthetic joint infections - RIFACute

France

Phase II and Phase III (Integrated) EU CTIS Study details

Joint Infection trials by city

Joint Infection in Toronto Joint Infection in Vancouver Joint Infection in Montreal Joint Infection in Calgary Joint Infection in Edmonton Joint Infection in Ottawa Joint Infection in Winnipeg Joint Infection in Quebec City Joint Infection in Hamilton Joint Infection in Kitchener Joint Infection in London Joint Infection in Halifax Joint Infection in New York Joint Infection in Los Angeles Joint Infection in Chicago Joint Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease